REPLY
13.9.2021 11:32:12 CEST | Business Wire | Press release
Following the success of the first edition and the satisfaction shown by all the students who participated in the training path, and now in working in corporate projects, Reply and the Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino announce that enrolment is now open for the second edition of the second-level Master's degree course in "Artificial Intelligence & Cloud Hands-on innovation" .
Starting in January 2022 , the Master’s offers 40 highly qualified students a professional specialisation path in the IT sector through its most innovative technologies: artificial intelligence, machine learning and cloud .
The lessons will be held in person at the Politecnico di Torino and will combine Politecnico di Torino professors and Reply specialists in a mix of theoretical lessons and practical live cases . During the programme, students will work in groups on live projects at Reply , where they will put into practice the knowledge acquired in the classroom.
The Master's is open to students who have previously obtained a Master's degree in either Computer Science, Computer Engineering, Automation Engineering, Telecommunications Engineering, Electronic Engineering and Cybersecurity (the degree must be completed by December 31, 2021). The entire course is in English and it is open to international entrants.
Applications should be submitted online by October 22, 2021 following the instructions available at master.reply.com . This will be followed by an evaluation process in which a commission made up of members of the Politecnico di Torino and Reply professionals will assess the candidates' curricula, educational background and professional experience. The commission will also meet each candidate for an individual interview.
The “Earn While You Learn” formula has also been confirmed for this second edition. Reply commits to hire the selected candidates right from the start of the programme and to bear all the costs of participation in the Master’s for those who accept the job offer.
“Through this specialisation path, in collaboration with the Politecnico di Torino, we aim to create an elite group of students who are highly qualified in the most innovative IT issues and to progressively include these students in our projects” explains Filippo Rizzante, Reply CTO. “Artificial intelligence, machine learning and cloud are fundamental for Reply and for our customers, which is why we want to train students in these technologies right from the start.”
"The Master’s in collaboration with Reply – explains the Specializing Master's Programmes and Lifelong Learning School’s Director, Prof. Paolo Neirotti – is one of the initiatives of excellence that the Master’s School designs and delivers. The programme has a custom-made approach for sector leaders and confirms that the digital transformation requires the various profiles coming out of Master's degrees in Engineering to have hyper-technical specialisation. As a technical university, we are well prepared to provide this specialisation as we design Master's programmes that integrate, recombine and extend the different scientific areas within our second-level training offer. On top of this we also rely on our experience in company applied research and technology."
Politecnico di Torino is recognized as one of the most respected universities in Europe and Reply is a company that has made innovation and technological specialization its flagship. Both entities have joined forces to create a training path for excellence; one aimed at preparing the professionals the industry needs to face the challenges of the future.
More information available at master.reply.com and https://didattica.polito.it/master/ai_cloud/2022/at_a_glance .
°°°
REPLY
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino
The Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino was founded in December 2011 with the aim of organising and managing first-level and second-level Master’s programmes, as well as Lifelong Learning courses, including executive courses. The School stands out for the variety and multidisciplinary nature of its Master’s programmes and training courses, which are an expression of the many scientific and cultural areas present within a research university such as the Politecnico di Torino. The training offer proposed by the School covers several disciplinary areas in order to provide support to companies and public and private institutions, so that they develop their transition ability towards new technological, economic and social paradigms (e.g. electrification, sustainability, digital transformation). Consistent with the polytechnic tradition, the scientific areas underpinning the School's continuing education offer are related to Industry 4.0, new forms of mobility, development and technology transfer in aerospace, digital transformation of businesses, public administration and society, environmental and energy sustainability, digitalisation in construction, new approaches and new frontiers in design, and the design of territories in the perspective of resilience.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005045/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
